Back Foley Viewpoints IP Issues for Combination Products at the Intersection of Nanotechnology and Medical Devices April 24, 2007 Share on LinkedInShare on TwitterPrintShare by EmailShare Back to top Medical Device Industry Team Chair Andrew E. Rawlins presented “IP Issues for Combination Products at the Intersection of Nanotechnology and Medical Devices” on April 24, 2007. Author(s) Andrew E. Rawlins [email protected] Washington, D.C. 202.672.5349 Related Insights View All Posts December 18, 2025 Foley Viewpoints NAIC Issues Statement Regarding AI Executive Order On December 16, 2025, the National Association of Insurance Commissioners (NAIC) issued a statement (the NAIC Statement), on the December… December 17, 2025 Foley Viewpoints SEC and FINRA Increase Oversight of Cross-Border Small-Cap Offerings Executive Summary In late 2025, the U.S. Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority (FINRA)… December 17, 2025 Foley Viewpoints Amended Regulation S-P: Here to Stay and Being Examined in 2026 Last month, the U.S. Securities and Exchange Commission (SEC) Division of Examinations released its Fiscal Year 2026 “Examination…
